MORE►
Emory University
TFF Pharmaceuticals CEO Dr. Harlan Weisman [Photo TFF, Background DI Studio]
Fort Worth’s TFF Pharmaceuticals Partners to Develop Dry Powder-Inhaled mRNA Treatment for Flu and COVID
by David Seeley | Sep 13, 2024
Respiratory illnesses like influenza and COVID can change rapidly, requiring the nimble development and delivery of antiviral drugs to combat them. TFF is now partnering with Atlanta's Emory University and the Biomedical Advanced Research and Development Authority (BARDA) to test the feasibility of converting an Emory-developed mRNA antiviral into a dry powder formulation that needs no cold-chain storage.
by David Seeley |
Apr 17, 2023
Subtle changes in the way people speak could help doctors diagnose cognitive impairment and Alzheimer’s disease—even before symptoms begin to show. That's according to a new study led UT Southwestern researcher Ihab Hajjar, M.D., working with a research team at Emory University in Atlanta. After being given standard cognitive assessments, 206 participants were asked to talk about an art work. Here's what happened next.
MORE►
by Dallas Innovates | Staff Report |
Mar 28, 2023
UT Southwestern says the funding award is a significant step towards improving postpartum health outcomes for low-income women of color. The study aims to determine the best way to use technology to improve access to maternal health care and decrease complications after birth.
MORE►
